BeOne Medicines (ONC) Other Operating Expenses (2017 - 2023)

BeOne Medicines (ONC) has reported Other Operating Expenses for 7 consecutive years, with $188000.0 the latest figure, recorded in Q2 2023.

• In Q2 2023, Other Operating Expenses fell 99.74% year-over-year to $188000.0; the TTM figure through Mar 2024 stood at $188000.0 (up 100.29% YoY), while the FY2020 annual figure was $71.5 million, down 1.4% from the prior year.
• Other Operating Expenses grew to $188000.0 in Q2 2023 per ONC's latest filing, from $187000.0 in the prior quarter.
• Across five years, Other Operating Expenses topped out at $76.7 million in Q3 2022 and bottomed at -$213.5 million in Q4 2022.
• Historically, Other Operating Expenses has averaged $8.0 million across 5 years, with a median of $19.4 million in 2019.
• Annual changes were most pronounced in 2019 — Other Operating Expenses soared 229.08% — and 2021, when it tumbled 649.82%.
• BeOne Medicines' Other Operating Expenses stood at $18.3 million in 2019, then increased by 16.11% to $21.3 million in 2020, then sank by 649.82% to -$116.9 million in 2021, then plunged by 82.61% to -$213.5 million in 2022, then surged by 100.09% to $188000.0 in 2023.
• Business Quant data shows ONC's Other Operating Expenses at $188000.0 in Q2 2023, $187000.0 in Q1 2023, and -$213.5 million in Q4 2022.